Elyxium Wealth’s Sarepta Therapeutics SRPT Stock Holding History

Elyxium Wealth’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$200	Buy	+11	New	+$206	﹤0.01%	1445

Other funds holding SRPT

Generali Investments CEE Prague, Czech Republic $2.11B AUM 18.35% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

Raiffeisen Bank International Vienna, Austria $8.69B AUM 38.11% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

Sigma Planning Corp Ann Arbor, Michigan $3.88B AUM 23.38% 1-Year Est. Return

Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return

Elyxium Wealth's SRPT Position: Q3 2026 in Review

Elyxium Wealth opened a new position in Sarepta Therapeutics (SRPT) in Q3 2026: 11 shares worth $200. The stake represents ﹤0.01% of the portfolio and ranks #1445 among its holdings.

52 funds tracked by Wall St. Rank hold SRPT as of Q3 2026.

Elyxium Wealth held 11 shares of Sarepta Therapeutics worth $200 as of Q3 2026.
Sarepta Therapeutics was a new Elyxium Wealth position in Q3 2026.
Sarepta Therapeutics made up ﹤0.01% of Elyxium Wealth's portfolio in Q3 2026, its #1445 holding.
52 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2026.

Based on Elyxium Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.